Dr. Keith Vossel’s interview with Jane King from Nasdaq was featured on WISHTV.com, Wednesday’s Business Headlines, on November 30th about who may benefit from the lecanemab clinical trial study.
The Risk and Benefits of the New Alzheimer’s Drug
Related Articles
